Association of glycogen synthase kinase-3β with Parkinson's disease (review). - Wikidata - wikimedia - TriplyDB

Association of glycogen synthase kinase-3β with Parkinson's disease (review).

Association of glycogen synthase kinase-3β with Parkinson's disease (review).

http://www.wikidata.org/entity/Q38200488

about

Chronic over-nutrition and dysregulation of GSK3 in diseases A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging Resveratrol: A Focus on Several Neurodegenerative Diseases Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β Pathway Insensitivity of PI3K/Akt/GSK3 signaling in peripheral blood mononuclear cells of age-related macular degeneration patients.α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production Prenatal alcohol exposure alters p35, CDK5 and GSK3β in the medial frontal cortex and hippocampus of adolescent mice Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.Use of a special Brazilian red-light emitting railroad worm Luciferase in bioassays of NEK7 protein Kinase and Creatine Kinase How does resveratrol influence the genesis of some neurodegenerative diseases?Salidroside inhibits steroid-induced avascular necrosis of the femoral head via the PI3K/Akt signaling pathway: In vitro and in vivo studies.

P2860

Q26738964-41E33E95-6E43-413B-AEEB-80AB1E98601B Q26741164-CB35481F-4A1A-4D09-A582-101C145D22A5 Q26768475-BF6718F7-45A6-48BB-BC0E-D343B2F99BCD Q26800952-AD44249B-C2F6-46CB-A048-DCD57B7C17B3 Q28390865-7D23B6BC-6B70-4138-8599-2720CC6D8A4A Q33768692-CCCAE321-E3C7-4D05-8414-DF01F340F4CA Q33841149-451EEC8D-5382-42BA-A753-9AC391E65E48 Q34200115-EB83A46D-8236-4F61-920A-DA9F3773E87B Q37603383-FC20A888-40A4-48CF-B10C-0BA95A631ACC Q38671688-918911B4-C915-4946-8164-59F3015F63DB Q38717050-F4066F64-80DD-4525-AEA3-580DC198F573 Q47246356-840B1D16-179B-487B-994B-2507A67FB8F6

P2860

Association of glycogen synthase kinase-3β with Parkinson's disease (review).

http://www.wikidata.org/entity/Q38200488

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Association of glycogen synthase kinase-3β with Parkinson's disease (review).

@en

type

label

Association of glycogen synthase kinase-3β with Parkinson's disease (review).

@en

prefLabel

Association of glycogen synthase kinase-3β with Parkinson's disease (review).

@en

P1433

Q38200488-39656702-6900-478A-A270-F7095781C2DB

P1476

Q38200488-45F26528-579F-4794-811F-5A442DE97E71

P2093

Q38200488-160F70EB-1E61-43B3-9089-B17E50152059

Q38200488-3EC8EC0A-5426-4236-AC83-BDF05F140C3F

Q38200488-4A927753-86D2-4EE7-942F-F1B118E0EA68

Q38200488-AAA8E172-D8BE-4ECA-B76C-A594F1A7F79E

Q38200488-D9178ACD-7A2C-46BF-B448-BCEBE55BD2AE

P275

Q38200488-2EB1E192-F5EF-417E-B25F-A380C90829BF

P2860

Q38200488-08AC4825-859A-4C4C-8DEC-D384634CC9CB

Q38200488-128178F2-500F-4FBC-BF12-78508887D8D5

Q38200488-13279F62-8E48-42F8-B7AA-3EC4C2B0A769

Q38200488-15A836EC-4856-4FBD-A703-E737C543804B

Q38200488-17D569F7-FC95-47F7-93C6-A783046C74C9

Q38200488-1828860C-281B-4624-B46D-C4AF37CA8E8A

Q38200488-1A9E2307-A145-42C0-802D-A1E0B697C861

Q38200488-1DFEBDAC-CFEA-49CC-BD32-95F1CB70100D

Q38200488-1E2C66DE-5504-4CAB-9BF6-86BD850834C1

Q38200488-2150E130-21E3-460D-BF28-C293725E3972

P304

Q38200488-88DE4A33-158B-49C0-A69D-D6159D0F0B10

P31

Q38200488-082925BE-7392-42BA-BD1D-749D9F22E937

Q38200488-7A4B9112-DCCF-43E3-8B0C-379487FFB7DE

P356

Q38200488-B5A25846-8DFD-4355-AA50-D327A29D9A48

P433

Q38200488-D417B30E-F4DC-42EA-A1B4-072F9D8570A3

P478

Q38200488-D915B8CB-356F-4613-B865-2FE5A1B16AA2

P5008

Q38200488-FB8413D6-7F65-4DF0-859D-9C260C9AFC59

P577

Q38200488-5870E231-F492-4914-B9E7-9E21FD337D33

Q38200488-860B9104-BD1B-4EB6-B00C-40330FA35461

P5875

Q38200488-AB7A7728-DB16-4600-B60F-F1336954C222

P698

Q38200488-83BF6A53-C1EF-4F7C-9156-6C281C5089AC

P921

Q38200488-3251B171-6632-45EC-B1B3-4714042D37DF

Q38200488-941A99F9-1F06-46EB-8547-58EBA3F31E47

Q38200488-9E5E3BC6-D231-469F-AC21-F038CDE2AAEF

Q38200488-E34EF228-593B-4494-BD9C-A1D78B12369C

P932

Q38200488-A5AFB4D5-D327-427E-A908-F6B114EEC53D

P356

P1433

Molecular Medicine Reports

P1476

Association of glycogen synthase kinase-3β with Parkinson's disease (review).

@en

P2093

Da-Wei Li

http://www.w3.org/2001/XMLSchema#string

Guang-Ren Li

http://www.w3.org/2001/XMLSchema#string

Min Yao

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

Zhi-Qiang Liu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

A role for alpha-synuclein in the regulation of dopamine biosynthesis

Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1

The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria

How mitochondria produce reactive oxygen species

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition

alpha-Synuclein locus triplication causes Parkinson's disease

P304

2043-2050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2014.2080

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261221020

http://www.w3.org/2001/XMLSchema#string

P698

24681994

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

macromolecular substances

P932

4055480

http://www.w3.org/2001/XMLSchema#string